Acral Peeling Skin Syndrome

Acral Peeling Skin Syndrome is a rare genetic skin condition. The top layer of the skin (the outermost “dead” layer) peels off easily. It usually happens on the hands and feet. The peeling is often painless. Heat, sweat, moisture, and friction make it worse. It usually starts at birth or in early infancy and continues through life. There is no scarring because the peeling is very superficial. APSS is inherited in an autosomal recessive way. Most known cases are due to changes (mutations) in a skin enzyme gene called TGM5. A smaller number are due to mutations in CSTA. These genes help the outer skin layer stick together; when they do not work, the top layer separates and peels. There is no cure yet. Care focuses on gentle skin protection, moisturizers, and avoiding triggers. Genetic Rare Diseases CenterMedlinePlusPubMed+1

Acral Peeling Skin Syndrome (APSS) is a rare genetic skin condition. “Acral” means the skin on the hands and feet. In APSS, the very top layer of the skin (the outer “dead” layer called the stratum corneum) loosens and peels off, mostly on the hands and feet. The peeling is usually painless or only mildly uncomfortable. The skin underneath may look pink or slightly red for a short time and then heals without scars. APSS often starts at birth or early childhood. The peeling gets worse with heat, sweating, humidity, water exposure, friction (rubbing), or tight/occlusive gloves and shoes. APSS is autosomal recessive, which means a child develops it when both parents carry a silent (carrier) change in a specific gene. The most common gene is TGM5 (transglutaminase 5). Less often, changes in CSTA (cystatin A) can cause a very similar acral peeling picture. These genes help the outer skin cells “glue” together. When they don’t work properly, the outer cells separate too easily and peel. MedlinePlusPubMed+1PMC

What is happening in the skin?

The outer skin layer is like tiles held by cement and tiny rivets. TGM5 is one of the enzymes that helps cross-link (glue) proteins to build a tough “cornified envelope.” CSTA helps control skin-breaking enzymes so the outer cells don’t fall apart too soon. If TGM5 is weak or missing, or if CSTA cannot protect the links between cells, the upper skin separates more easily, especially when wet, hot, or rubbed. This separation happens very superficially (sub-corneal or intra-corneal level), so blisters—if present—are thin, and healing is quick with little or no scarring. MedlinePlusPubMed

---

Other names

• Acral Peeling Skin Syndrome (APSS)

• Peeling skin syndrome, acral type

• Peeling Skin Syndrome type 2 (PSS2) / Acral PSS / Localized PSS (OMIM 609796)
  These are all used in medical references to describe the acral-predominant form. chorobyrzadkie.gov.plMedlinePlus

---

Types

1. Classic APSS due to TGM5 variants (most common):
   Localized, mostly acral peeling with onset at birth/childhood; worse with heat, humidity, water, and friction; autosomal recessive inheritance. MedlinePlus

2. APSS-like disease due to CSTA variants (less common):
   Can look very similar on hands and feet; some families also have broader, fine scaling (“exfoliative ichthyosis” features). PubMed

3. Broader Peeling Skin Syndromes (PSS) family (context):
   Dermatologists also describe generalized (whole-body) non-inflammatory and inflammatory types, and several genetic subtypes (e.g., CHST8, FLG2, CAST) that are not the classic acral pattern but help show the bigger family of related conditions. APSS sits within this wider group as the acral-dominant form. KargerScienceDirectDermNet®

---

Causes

Key point: The root cause of APSS is genetic (inherited). The peeling episodes are then triggered or worsened by everyday factors like heat, moisture, and friction.

Primary genetic causes

1. TGM5 gene variants (transglutaminase 5): the main known cause of APSS. Faulty cross-linking makes the outer skin layer weak, so it peels. Autosomal recessive. MedlinePlus

2. CSTA gene variants (cystatin A): a less common cause that reduces protection against proteases, so cell-to-cell glue breaks down faster and skin peels. Autosomal recessive. PubMed

3. Autosomal recessive inheritance pattern: both parents are carriers, and the child inherits both altered copies. MedlinePlus

4. Founder or family-specific variants: in some regions or families, a particular TGM5 or CSTA change runs in the family and can appear in several relatives. (This pattern is described across case series). MedlinePlus

Triggering and worsening factors (not root causes, but increase peeling)

5. Heat: warms the skin and increases sweating, softening the outer layer so it lifts and peels. MedlinePlusPMC

6. Humidity and moisture: water swells the stratum corneum and weakens the bonds, so sheets of skin lift off. MedlinePlus

7. Prolonged water exposure (bathing, swimming, dishwashing): maceration makes peeling more obvious after soaking. PMC

8. Friction or rubbing: tight shoes, repetitive gripping, or manual work shear the fragile top layer. MedlinePlus

9. Occlusion (gloves, bandages, sports tape): traps sweat and heat, leading to maceration and peeling. PMC

10. Hyperhidrosis (sweaty palms/soles): constant moisture keeps the stratum corneum soft and easy to peel. (Common clinical observation in reports.) MedlinePlus

11. Minor trauma: small knocks or scuffs start a peel edge that spreads. PubMed

12. Seasonal weather (hot, wet seasons): flare-ups in warm months or monsoon due to heat/humidity. MedlinePlus

13. Detergents/soaps/solvents: increase dryness after swelling–drying cycles and disturb barrier proteins, so peeling repeats. (General dermatology principle; noted as aggravating in PSS.) VisualDx

14. Long walks/runs or sports: prolonged friction inside shoes or sports gear worsens acral sites. MedlinePlus

15. Tight footwear/gloves: chronic occlusion + friction = more peeling. PMC

16. Rapid rehydration–drying cycles: repeated wetting/drying stresses the already fragile outer layer. MedlinePlus

17. Fever or high body temperature: like heat exposure, can trigger short flares. MedlinePlus

18. Sun/UV with sweating: UV itself is not the main driver, but combined heat/sweat can aggravate. VisualDx

19. Stress-related sweating: palms/soles sweat more with stress, indirectly worsening peeling. MedlinePlus

20. Secondary irritation or infection: rare; scratching or maceration can invite bacteria, which then irritates and loosens edges further (usually mild and short-lived in APSS). IJDVL

---

Symptoms and signs

1. Superficial peeling on hands/feet (most visible on palms and soles; sometimes on backs of hands/feet). Often in thin sheets. Usually painless. MedlinePlus

2. Onset at birth or early life: many families notice it in newborns or young children; others present later. MedlinePlus

3. Worse with heat, moisture, friction: for example after a bath, on a hot day, or with tight shoes. MedlinePlus

4. Mild redness at edges after peeling: the fresh skin looks pink but heals quickly. MedlinePlus

5. Occasional thin blisters: very superficial, break easily, and leave peeling. PubMed

6. Mild itch or burning: short-lived and often triggered by sweating or rubbing. MedlinePlus

7. Dryness between episodes: the skin may feel dry, with faint scaling. IJDVL

8. No scarring: skin returns to normal look after a short time. MedlinePlus

9. No nail, hair, or teeth problems in classic APSS: those areas are generally normal. (Important for distinguishing from other syndromes.) MedlinePlus

10. Normal general health: APSS affects skin only; no internal organ disease. MedlinePlus

11. Recurrent pattern: cycles of peeling come and go throughout life. MedlinePlus

12. Trigger-linked flares: episodes after swimming, dishwashing, long hikes, or glove use. PMC

13. Skin “maceration” look: after soaking, acral skin looks white-wrinkly and lifts off easily. PMC

14. Tenderness only if over-peeled: deeper cracks can feel sore briefly but heal fast. MedlinePlus

15. Psychosocial impact: embarrassment or worry about hand appearance despite mild physical symptoms; reassurance helps. (Common in rare skin disorders.) IJDVL

---

Diagnostic tests

Doctors usually make the diagnosis from the story and exam, and then confirm it with genetic testing (TGM5, and sometimes CSTA). Skin biopsy is used when the picture is unclear. Imaging and biophysical tools help document the level of skin separation and barrier weakness.

A) Physical exam (bedside observation)

1. Targeted skin exam of hands/feet: doctor looks for thin, superficial sheets of peeling on palms/soles and backs of hands/feet, often with minimal redness and no scars. Pattern favors APSS. MedlinePlus

2. Trigger review during exam: history of flares with heat, humidity, water, friction, or occlusion supports the diagnosis. MedlinePlus

3. Distribution check: mostly acral; face and mucosa are spared; hair, nails, teeth normal in classic APSS. Helps separate APSS from other peeling syndromes. MedlinePlus

4. Family history and inheritance clues: unaffected parents, siblings, or cousins in recessive families; consanguinity may be present in some pedigrees. MedlinePlus

B) Manual tests (simple provocation or bedside maneuvers)

5. Water-immersion provocation (short soak): soaking a hand/foot for several minutes may reveal quick maceration and easy lifting of the outer layer—typical for APSS. (Used in case reports to demonstrate trigger-linked peeling.) PMC

6. Friction/occlusion challenge (cautious): gentle rubbing or wearing an occlusive glove for a brief period may reproduce superficial peeling; done carefully to avoid injury. PMC

7. Edge-lift test: the clinician gently lifts an existing loose edge; the sheet separates very superficially and painlessly, showing sub-corneal cleavage. (Characteristic clinical behavior in APSS.) PubMed

8. Nikolsky-type assessment (very gentle): light lateral pressure over affected skin may extend the superficial peel (sub-corneal), unlike deeper blistering diseases. Helps localization of split. PubMed

C) Lab & pathological tests (confirmatory)

9. Genetic testing—TGM5** sequencing:** the key confirmatory test; finds disease-causing variants in most APSS patients. MedlinePlus

10. Genetic testing—CSTA** sequencing:** ordered when TGM5 is negative or features suggest CSTA-related disease; confirms rarer APSS-like cases (sometimes with exfoliative ichthyosis). PubMed

11. Skin biopsy—routine histology: shows very superficial epidermal split (sub-corneal/intra-corneal) with minimal inflammation, supporting APSS over deeper blistering diseases. PubMed

12. Electron microscopy (when needed): can show separation within the stratum corneum and disturbed corneodesmosomes (the “rivets” between skin cells). Used in complex cases or research. PubMed

13. Transglutaminase 5 activity or immunolabeling (specialized): reduced/absent TGM5 function or altered pattern supports TGM5-related APSS (mainly in research centers). MedlinePlus

14. Rule-out tests for look-alikes: swabs/cultures if secondary infection is suspected, or patch testing if contact dermatitis is in the differential. (To exclude other causes of hand/foot peeling.) VisualDx

D) Electrodiagnostic / biophysical measurements (noninvasive device-based)

15. Transepidermal Water Loss (TEWL): a handheld sensor measures water escaping through the skin. Higher TEWL at acral sites suggests a weaker barrier after peeling. (Widely used biophysical tool in dermatology research.) ScienceDirect

16. Skin capacitance (corneometry): measures skin hydration; can document maceration during flares and dryness between episodes. (Common skin physiology method.) ScienceDirect

17. Evaporimetry/impedancemetry: additional sensors that quantify barrier function and help track response to routine care (emollients/avoidance). (Supportive, not diagnostic alone.) ScienceDirect

E) Imaging tests (in-clinic visualization)

18. Dermoscopy (handheld magnifier): shows very superficial, plate-like scale/peeling edges without deeper erosions; simple, quick documentation. (Widely used in dermatology.) VisualDx

19. Reflectance confocal microscopy (RCM) or Optical Coherence Tomography (OCT): noninvasive imaging can visualize the exact skin layer where splitting occurs (upper epidermis), supporting APSS when biopsy is avoided. (Used in specialty centers.) VisualDx

20. High-frequency ultrasound (HFUS) of skin (optional): helps rule out deeper blistering by showing intact lower epidermis/dermis in APSS; also documents edema only if present. (Adjunctive, research/tertiary care use.) VisualDx

Non-pharmacological treatments

(practical, day-to-day steps; simple words; real-world routines. Items 1–15 include physiotherapy/hand-foot care, mind-body, “gene education,” and patient education as requested.)

Important: These measures are supportive. They do not “cure” the gene change. They reduce triggers and protect the skin. OrphaGenetic Rare Diseases Center

1. Thick plain moisturizers (petrolatum, soft paraffin) twice daily
   Purpose: lock in water; reduce peeling sheets.
   Mechanism: occlusion reduces water loss; helps the outer layer stay flexible.
   Benefits: fewer flakes, less cracking after bathing. Medical News Today

2. Ceramide-rich or urea 10% creams at night
   Purpose: barrier repair and gentle softening.
   Mechanism: ceramides restore lipids; low-strength urea draws water and smooths rough edges.
   Benefits: smoother skin, easier to manage small peels. (Use higher strengths only if advised.) Orpha

3. Short, lukewarm baths or showers
   Purpose: clean without swelling and over-hydrating the stratum corneum.
   Mechanism: less water exposure = less maceration and less sheet-like peeling.
   Benefits: calmer skin after bathing. Genetic Rare Diseases Center

4. Pat-dry + immediate “soak-and-seal”
   Purpose: trap bath water in the skin.
   Mechanism: apply ointment within 3 minutes after bathing.
   Benefits: better hydration and fewer peels. Medical News Today

5. Antiperspirant care for feet and palms (see drug section for options)
   Purpose: reduce sweat, which worsens peeling.
   Mechanism: blocks sweat ducts; less moisture = fewer flares.
   Benefits: longer “quiet” periods. BioMed Central

6. Breathable socks, shoes, and glove choices
   Purpose: limit heat and dampness; reduce friction.
   Mechanism: wicking fabrics, mesh, leather, or perforated uppers.
   Benefits: fewer flare-ups in hot weather. Genetic Rare Diseases Center

7. Protective cotton liners under rubber gloves when wet work is needed
   Purpose: reduce water exposure and rubbing.
   Mechanism: creates a dry buffer; change liners if damp.
   Benefits: less post-work peeling. Orpha

8. Hydrocolloid spots or silicone gel sheeting for tender areas
   Purpose: cushion and protect mild splits.
   Mechanism: moist wound environment helps shallow cracks re-adhere.
   Benefits: faster comfort and fewer snags. Orpha

9. Trigger map (simple diary)
   Purpose: find patterns (hot days, sports, detergents).
   Mechanism: link activity or weather to flare.
   Benefits: targeted prevention. Genetic Rare Diseases Center

10. Gentle hand-foot “physiotherapy” routine
    Purpose: keep skin flexible, prevent painful splits around joints.
    Mechanism: warm soak 5 minutes → pat dry → moisturizer → slow range-of-motion while skin is supple.
    Benefits: easier finger and toe movement during flares. (APSS is usually painless; this is for comfort and function.) Orpha

11. Callus care education (no cutting, no harsh blades)
    Purpose: avoid deeper injury.
    Mechanism: replace cutting with nightly emollient + gentle pumice once weekly if advised.
    Benefits: fewer cracks/infections. Orpha

12. Mind–body tools for habit control (not skin curative)
    Purpose: reduce stress-sweat and skin-picking habits.
    Mechanism: brief breathing practice, urge-surfing, gloves at night.
    Benefits: less mechanical trauma. Orpha

13. Sun-smart habits
    Purpose: prevent sun-triggered peeling bursts.
    Mechanism: shade, clothing, and sunscreen for acral skin if exposed.
    Benefits: fewer flares in summer. Wikipedia

14. Household product swap
    Purpose: reduce irritants.
    Mechanism: mild, fragrance-free cleansers and detergents; avoid solvents.
    Benefits: calmer, less dry skin. Orpha

15. Family education & “gene literacy”
    Purpose: understand autosomal recessive inheritance; set expectations.
    Mechanism: simple counseling about TGM5/CSTA; offer genetic testing discussion.
    Benefits: earlier recognition in siblings; realistic long-term plan. MedlinePlusPubMed

16. Weather and workplace adjustments
    Portable fan; breaks to dry hands/feet; change into dry socks mid-shift. BioMed Central

17. Moisture-wicking insoles and sock rotation
    Two pairs/day in hot months; air shoes overnight. Genetic Rare Diseases Center

18. Night occlusion for stubborn dry spots
    Petrolatum + cotton glove/sock at bedtime, 2–3 nights/week. Medical News Today

19. Hydration and room humidity balance
    Avoid very high humidity; use fan/AC when muggy. BioMed Central

20. Nail care to avoid catching edges
    Keep nails short, smooth; avoid picking lifted skin. Orpha

21. Activity tweaks
    Choose lower-friction sports (cycling with gloves, swimming with quick dry aftercare). Genetic Rare Diseases Center

22. Travel kit
    Mini ointment, hydrocolloid pads, spare socks, antiperspirant wipes. Medical News Today

23. School/work notes
    Permission for glove use, extra breaks to change socks or apply ointment. Genetic Rare Diseases Center

24. Patient community support
    Peer tips for routines and products; reduces trial-and-error stress. Medical News Today

25. Regular dermatologist check-ins
    To update care, confirm diagnosis, and rule out look-alikes. UpToDate

---

Drug treatments

Note: There is no approved, disease-modifying medicine for APSS. These medicines help symptoms or complications. Use only with clinician advice—especially in infants and children. OrphaGenetic Rare Diseases Center

1. Plain petrolatum (topical emollient/occlusive)
   Dose/time: thin layer 2–4×/day and after bathing.
   Purpose: reduce peeling and cracks.
   Mechanism: occlusion and barrier support.
   Side effects: rare folliculitis if very thick. Medical News Today

2. Ceramide moisturizers (topical barrier therapy)
   Dose: nightly; more often if dry.
   Purpose/mechanism: restore skin lipids; support cohesion of outer layer.
   Side effects: minimal; check for fragrance sensitivities. Orpha

3. Urea cream 10% (topical humectant/keratolytic)
   Dose: once nightly to thick areas.
   Purpose: soften rough rims of peeled skin.
   Mechanism: draws water; gentle corneodesmolysis at low strength.
   Side effects: stinging on open splits; avoid high strengths unless supervised. Orpha

4. Lactic acid 5–10% (topical keratolytic)
   Dose: nightly or every other night on thicker areas.
   Purpose: smooth edges; reduce catching.
   Side effects: sting/irritation; avoid broken skin. Orpha

5. Aluminum chloride hexahydrate 20% (topical antiperspirant)
   Dose: nightly to palms/soles for 1–2 weeks, then 1–3×/week maintenance.
   Purpose: less sweat → less peeling.
   Mechanism: temporary sweat duct plugging.
   Side effects: sting/irritant dermatitis; use on dry skin. BioMed Central

6. Glycopyrrolate (oral anticholinergic, off-label for hyperhidrosis)
   Dose: clinician-directed (often 1–2 mg once or twice daily in adults).
   Purpose: reduce sweating when topical fails.
   Side effects: dry mouth, constipation, blurred vision; avoid overheating. (Off-label—discuss risks.) Orpha

7. Botulinum toxin type A (intradermal injections for hyperhidrosis)
   Dose: clinician-performed sessions every 4–6 months.
   Purpose: reduce sweat triggers.
   Mechanism: blocks acetylcholine at sweat glands.
   Side effects: injection pain; temporary hand weakness if dosing in palms is high. Orpha

8. Topical corticosteroids (low-to-mid potency, short courses)
   Dose: thin layer once daily for 3–5 days during inflamed flares.
   Purpose: calm redness/itch from irritation.
   Mechanism: anti-inflammatory.
   Side effects: skin thinning if overused; avoid routine long-term use in APSS (baseline is non-inflammatory). UpToDate

9. Topical calcineurin inhibitors (tacrolimus/pimecrolimus)
   Dose: once or twice daily for short periods on irritated sites.
   Purpose: steroid-sparing anti-inflammatory.
   Side effects: transient burning; avoid on open splits. (Evidence limited.) UpToDate

10. Oral nonsedating antihistamines
    Dose: standard daily doses.
    Purpose: help itch when present.
    Mechanism: H1 receptor blockade.
    Side effects: rare drowsiness. Orpha

11. Topical antiseptics (chlorhexidine wash, dilute bleach baths per clinician advice)
    Dose: intermittent, for recurrent infections.
    Purpose: lower bacterial load.
    Mechanism: broad-spectrum antimicrobial effect.
    Side effects: dryness/irritation if too frequent. Orpha

12. Topical or oral antibiotics (only for proven infection)
    Dose: clinician-directed course.
    Purpose: treat secondary impetigo/cellulitis.
    Side effects: resistance risk; use only when needed. Orpha

13. Barrier repair ointments with cholesterol/free fatty acids
    Dose: nightly.
    Purpose/mechanism: lipid balance to support cohesion.
    Side effects: minimal. Orpha

14. Pain control for fissures (topical anesthetic patches short term)
    Dose: as advised; short contact.
    Purpose: comfort while healing.
    Side effects: local irritation; avoid overuse. Orpha

15. Super-glue (cyanoacrylate) for small splits (clinician-taught method)
    Dose: tiny film to clean, dry crack; protect after.
    Purpose: close shallow fissures.
    Side effects: irritation; avoid if infected. (A pragmatic technique some dermatologists teach.) Orpha

---

Dietary molecular supplements

1. Omega-3 fatty acids (e.g., fish oil 1–2 g/day EPA+DHA): anti-inflammatory milieu; may ease dryness.

2. Vitamin D (per deficiency status): supports epidermal differentiation; check blood levels first.

3. Vitamin E (100–200 IU/day short term): antioxidant support of lipid barrier.

4. Niacinamide (oral 250–500 mg/day or topical): barrier-support and transepidermal water-loss reduction.

5. Zinc (as zinc gluconate 10–20 mg elemental/day): cofactor for skin repair; avoid long-term excess.

6. Biotin (5–10 mg/day trial): limited data; some patients report nail/skin benefits.

7. Probiotics (strain-specific, daily): gut–skin axis support; evidence in eczema suggests barrier effects, may or may not help APSS.

8. Collagen peptides (5–10 g/day): may improve skin hydration/elasticity in general populations.

9. Oral ceramides/“phytoceramides”: small trials show improved hydration in dry skin; could support barrier.

10. Hyaluronic acid (120–240 mg/day): systemic hydration support, modest effects.
    These are general skin-health adjuncts; APSS-specific trials are lacking. Prioritize diet and topical care first. Orpha

---

Regenerative / stem-cell” drug

Honest status: There are no proven immune boosters, regenerative drugs, or stem-cell treatments for APSS in routine care in 2025. Below are research-direction ideas only, to explain future possibilities. No approved dosages exist. Do not try outside formal clinical studies. Orpha

1. Topical recombinant transglutaminase-5 (enzyme replacement): would try to restore the missing cross-linking activity on the surface. Investigational concept; no approved product. MedlinePlus

2. mRNA therapy for TGM5 in keratinocytes: transient expression via lipid nanoparticles to restore barrier proteins. Pre-clinical concept. MedlinePlus

3. Ex-vivo gene-corrected autologous epidermal grafts (similar rationale to EB): take patient keratinocytes, correct TGM5/CSTA, grow sheets, graft to acral sites. Theoretical for APSS; done for other genodermatoses. UpToDate

4. Topical protease inhibitors mimicking CSTA function: reduce excessive corneodesmosome breakdown. Conceptual; not approved. PubMed

5. Small-molecule chaperones to stabilize mutant TGM5: help misfolded enzyme function longer. Laboratory idea only. MedlinePlus

6. CRISPR-based in-vivo gene editing: targeted correction in skin stem cells. High-level research; not for clinical use in APSS. UpToDate

---

Surgeries

Clear answer: Surgery is rarely, if ever, indicated for APSS. Peeling is superficial, so cutting or grafting does not help and can create new wounds. Below explains “why not” and what limited procedures might be considered for special problems.

1. Skin grafting: Not recommended—the defect is not deep; grafts add risk without fixing the gene defect.

2. Excision of peeling skin: Not recommended—peeling recurs because the cause is genetic and superficial.

3. Sympathectomy for hyperhidrosis: Almost never—major surgery risk; non-surgical sweat control is preferred.

4. Nail surgery (partial avulsion) for recurrent painful nail-fold splits: only in rare cases with repeated infections; most do well with protection and emollients.

5. Debridement of infected cracks: limited, conservative debridement may be used during treatment of secondary infection; not disease-directed.
   Discuss procedural choices with a dermatologist; most patients never need surgery. Orpha

---

Preventions

1. Keep hands/feet cool and dry; use a fan in hot months.

2. Change sweaty socks quickly; carry a spare pair.

3. Use antiperspirant on palms/soles at night when safe for your skin.

4. Moisturize every evening and after bathing.

5. Avoid strong soaps/solvents; choose mild, fragrance-free products.

6. Wear breathable, well-fitting shoes; avoid rubber boots for long hours.

7. Use cotton glove liners for wet work; limit long water exposure.

8. Do not pick peeling edges; trim loose flaps with clean scissors if needed.

9. Sun-smart habits; avoid hot pavements barefoot.

10. Keep a trigger diary and plan around “hot, sweaty, high-friction” days. Genetic Rare Diseases CenterBioMed Central

---

When to see a doctor

• First diagnosis or if unsure whether it is APSS vs another condition.

• Peeling in a newborn or infant.

• Signs of infection: yellow crust, pus, spreading redness, fever, pain.

• Deep, painful cracks that do not heal with simple care.

• Blisters, bleeding, or scarring (not typical for APSS).

• Rapid worsening, or big effect on school, work, or sports.

• If you are planning pregnancy or want genetic counseling/testing. Genetic Rare Diseases Center

---

What to eat and what to avoid

• Eat more: water; balanced meals; oily fish (omega-3s); nuts and seeds; colorful vegetables and fruits; whole grains; protein sources for repair (eggs, legumes, lean meats).

• Consider (with clinician): vitamin D if low; zinc-rich foods (beans, seeds); fermented foods (yogurt) for general skin support.

• Avoid or limit: very spicy or salty foods before heat/sports if they make you sweat more; alcohol (vasodilation and sweat); harsh citrus/solvent exposure on hands while preparing food—use gloves if needed.

• Key point: diet helps general skin health. It does not fix the gene change. Daily topical care and trigger control matter most. Orpha

---

Frequently asked questions (FAQs)

1. Is APSS dangerous?
   Usually no. It is mainly a quality-of-life issue. Infections can happen if cracks form. Genetic Rare Diseases Center

2. Will it scar?
   Scarring is uncommon because the split is very superficial. Orpha

3. Is there a cure?
   No cure yet. Care focuses on protection, moisturizers, and trigger control. Orpha

4. Which gene is involved?
   Most often TGM5; sometimes CSTA. Both are recessive. MedlinePlusPubMed

5. Can it start in adulthood?
   Yes, rarely. Most begin at birth/infancy; a few present later. PMC

6. Why is heat or water a problem?
   They soften and swell the outer layer, making separation easier. Sweat and friction add to it. BioMed Central

7. Is it the same as keratolysis exfoliativa?
   No. That is a common, seasonal palm peeling; APSS is genetic and lifelong. Primary Care Dermatology Society

8. How is APSS diagnosed?
   By clinical features, ruling out look-alikes, and often genetic testing for TGM5/CSTA. Genetic Rare Diseases Center

9. Do steroids cure it?
   No. They may calm irritation, but routine long-term steroid use is not helpful. UpToDate

10. Can antihistamines help?
    They may help itch if present, but they do not stop peeling. Orpha

11. What about retinoids?
    Generally not needed and can irritate. Discuss with a dermatologist before considering. UpToDate

12. Are there special soaps?
    Use mild, fragrance-free cleansers; avoid harsh degreasers and frequent hot water. Orpha

13. Can I play sports?
    Yes. Choose breathable gear, change damp socks early, and moisturize after. Genetic Rare Diseases Center

14. Can APSS be prevented in a child?
    We cannot prevent the gene change. Genetic counseling can explain risks for future pregnancies. MedlinePlus

15. What is the long-term outlook?
    Most people live normal lives. Good routines greatly reduce flares. Genetic Rare Diseases Center

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 02, 2025.